Learn more about hemolytic uremic syndrome (HUS), thrombotic thrombocytic purpura (TTP), and treatment options during this workshop. Hear about the latest biomarkers for acute kidney injury. Discover the connection between the pulmonary system and the kidneys — and diseases that reflect this connection. Finally, this workshop will address the key issues that are seen in acute care as well as the best practices that we have learned.
Contact hours available until 4/16/2016.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Speaker, Faculty, Planners and Authors Conflict of Interest Disclosure: Speaker(s) have no disclosures to declare.
Planning Committee: • Annette Hood discloses that she is a member of the Amgen speakers’ bureau. • Denise Murcek discloses other financial/material support as an employee of the VA Medical Center. • Elizabeth St. John discloses other financial/material support as an employee of Fresenius Medical Care. • Kyra Trappett discloses other financial/material support as an employee of DaVita.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
Objectives: • Describe the need for biomarkers in acute kidney injury (AKI). • Define the role of biomarkers in AKI. • Discuss examples of promising biomarkers in AKI.
MD, FACP, FASN, HP,
Medical Director and Professor,
University of Virginia Health System
You must be logged in and own this session in order to